Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

In Silico Techniques Used for the Evaluation of Anticancer Metal-Based Compounds

Author(s): Manos Vlasiou*

Volume 23, Issue 5, 2023

Published on: 03 September, 2022

Page: [490 - 491] Pages: 2

DOI: 10.2174/1871520622666220802145433

« Previous Next »
[1]
Vlasiou, M.C.; Pafiti, K.S. Cell arrest and apoptosis induced by the next generation of vanadium based drugs: Action mechanism to structure relation and future perspectives. Anticancer. Agents Med. Chem., 2021, 21(16), 2111-2116.
[http://dx.doi.org/10.2174/1871520621666201222143839] [PMID: 33355058]
[2]
Tziouris, P.A.; Tsiafoulis, C.G.; Vlasiou, M.; Miras, H.N.; Sigalas, M.P.; Keramidas, A.D.; Kabanos, T.A. Interaction of chromium(III) with a N,N′-disubstituted hydroxylamine-(diamido) ligand: A combined experimental and theoretical study. Inorg. Chem., 2014, 53(21), 11404-11414.
[http://dx.doi.org/10.1021/ic501778d] [PMID: 25329981]
[3]
Hadjiadamou, I.; Vlasiou, M.; Spanou, S.; Simos, Y.; Papanastasiou, G.; Kontargiris, E.; Dhima, I.; Ragos, V.; Karkabounas, S.; Drouza, C.; Keramidas, A.D. Synthesis of vitamin E and aliphatic lipid vanadium(IV) and (V) complexes, and their cytotoxic properties. J. Inorg. Biochem., 2020, 208, 111074.
[http://dx.doi.org/10.1016/j.jinorgbio.2020.111074] [PMID: 32497827]
[4]
Vlasiou, M.C.; Ioannou, K.; Eleftheriou, C.; Pafiti, K.S.; Zacharia, L.C.; El-Shazly, M. Synthesis and biological evaluation of a new chalconate Co (II/III) complex with cytotoxic activity. J. Mol. Struct., 2022, 1249, 131567.
[http://dx.doi.org/10.1016/j.molstruc.2021.131567]
[5]
Ioannou, K.; Eleftheriou, C.; Drouza, C.; Pafiti, K.S.; Panayi, T.; Keramidas, A.D.; Zacharia, L.C.; Vlasiou, M.C. Novel zinc and vanadium (V) hydroquinonate complexes: Synthesis and biological solution evaluation. J. Mol. Struct., 2022, 1257, 132582.
[http://dx.doi.org/10.1016/j.molstruc.2022.132582]
[6]
Vlasiou, M.C.; Pafti, K.S. Screening possible drug molecules for COVID-19. The example of vanadium (III/IV/V) complex molecules with computational chemistry and molecular docking. Comput. Toxicol., 2021, 18, 100157.
[http://dx.doi.org/10.1016/j.comtox.2021.100157] [PMID: 33553857]
[7]
Ciancetta, A.; Genheden, S.; Ryde, U. A QM/MM study of the binding of RAPTA ligands to cathepsin B. J. Comput. Aided Mol. Des., 2011, 25(8), 729-742.
[http://dx.doi.org/10.1007/s10822-011-9448-7] [PMID: 21701919]
[8]
Anjomshoa, M.; Hadadzadeh, H.; Torkzadeh-Mahani, M.; Fatemi, S.J.; Adeli-Sardou, M.; Rudbari, H.A.; Nardo, V.M. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines. Eur. J. Med. Chem., 2015, 96, 66-82.
[http://dx.doi.org/10.1016/j.ejmech.2015.04.020] [PMID: 25874332]
[9]
Ebrahimi, M.; Khayamian, T.; Hadadzadeh, H.; Sayed Tabatabaei, B.E.; Jannesari, Z.; Khaksar, G. Spectroscopic, biological, and molecular modeling studies on the interactions of [Fe(III)-meloxicam] with G-quadruplex DNA and investigation of its release from bovine serum albumin (BSA) nanoparticles. J. Biomol. Struct. Dyn., 2015, 33(11), 2316-2329.
[http://dx.doi.org/10.1080/07391102.2014.1003195] [PMID: 25563680]
[10]
Abdel-Rahman, L.H.; Abu-Dief, A.M.; Aboelez, M.O.; Hassan Abdel-Mawgoud, A.A. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand. J. Photochem. Photobiol. B, 2017, 170, 271-285.
[http://dx.doi.org/10.1016/j.jphotobiol.2017.04.003] [PMID: 28456118]
[11]
Hadian Rasanani, S.; Eslami Moghadam, M.; Soleimani, E.; Divsalar, A.; Ajloo, D.; Tarlani, A.; Amiri, M. Anticancer activity of new imidazole derivative of 1R,2R-diaminocyclohexane palladium and platinum complexes as DNA fluorescent probes. J. Biomol. Struct. Dyn., 2018, 36(12), 3058-3076.
[http://dx.doi.org/10.1080/07391102.2017.1385538] [PMID: 29027501]
[12]
Afzal, M.; Al-Lohedan, H.A.; Usman, M.; Tabassum, S. Carbohydrate-based heteronuclear complexes as topoisomerase Iα inhibitor: Approach toward anticancer chemotherapeutics. J. Biomol. Struct. Dyn., 2019, 37(6), 1494-1510.
[http://dx.doi.org/10.1080/07391102.2018.1459321] [PMID: 29606083]
[13]
Abedanzadeh, S.; Karami, K.; Rahimi, M.; Edalati, M.; Abedanzadeh, M.; Tamaddon, A.M.; Jahromi, M.D.; Amirghofran, Z.; Lipkowski, J.; Lyczko, K. Potent cyclometallated Pd(II) antitumor complexes bearing α-amino acids: Synthesis, structural characterization, DNA/BSA binding, cytotoxicity and molecular dynamics simulation. Dalton Trans., 2020, 49(42), 14891-14907.
[http://dx.doi.org/10.1039/D0DT02304C] [PMID: 33075117]
[14]
Scaff, M.D.J.; Vieira, R.S.H.; Cesar, C.C.; Álvaro, F.S.G.; Ionta, M.; Almeida, F.; Bezerra, V.R.; Imaculada, F.B.M.; Carlos, D.A. Novel ruthenium(II) complexes with cimetidine: DFT calculations and in vitro cytotoxic activities against glioblastoma cell lines. Inorg. Chim. Acta, 2020, 506, 119501.
[http://dx.doi.org/10.1016/j.ica.2020.119501]
[15]
Xu, C.X.; Liu, L.Y.; Lv, B.; Zhao, H.Y.; Cao, Q.; Zhai, T.; Mao, Z.W. Two novel fan-shaped trinuclear Pt(ii) complexes act as G-quadruplex binders and telomerase inhibitors. Dalton Trans., 2020, 49(27), 9322-9329.
[http://dx.doi.org/10.1039/D0DT01767A] [PMID: 32579629]
[16]
Vicente-Escobar, J.O.; García-Sánchez, M.Á.; Serratos, I.N.; Millán-Pacheco, C.; Tello-Solís, S.R. Binding of two tetrasulfophthalocyanines (Fe(III) and metal-free) to lysozyme: Fluorescence spectroscopic and computational approach. J. Fluoresc., 2021, 31(3), 787-796.
[http://dx.doi.org/10.1007/s10895-021-02710-7] [PMID: 33665743]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy